NCT05323955 2026-03-17
BRIDGET
Duke University
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT05673928 2026-01-21
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04158947 2020-05-12
HER2BAT
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown